BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Vigil Neuroscience, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2025-05-15 4:42 pm Purchase | 2025-03-31 | 13G | Vigil Neuroscience, Inc. VIGL | BIOTECHNOLOGY VALUE FUND L P | 4,734,500 9.990% | 1,994,773![]() (+72.81%) | Filing |
2022-08-26 5:11 pm Purchase | 2022-08-16 | 13G | Vigil Neuroscience, Inc. VIGL | BIOTECHNOLOGY VALUE FUND L P | 2,739,727 7.500% | 2,739,727![]() (New Position) | Filing |